Elevated soluble interleukin 2 receptor levels found among kidney transplant recipients

Transplantation

Volumn 64, Issue 8, 1997, Pages 1202-1205

  Pickeral, John J ^a   Marcus, Richard J ^a   Hsia, Shyuan ^a   Miller, Lynnette L ^a   Nghiem, Dai D ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; INTERLEUKIN 2 RECEPTOR; OKT 3;

ARTICLE; BINDING AFFINITY; CADAVER DONOR; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; RECEPTOR BINDING;

CADAVER; CREATININE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; PREDNISOLONE; RECEPTORS, INTERLEUKIN-2; SOLUBILITY; TISSUE DONORS;

EID: 0030693393     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199710270-00021     Document Type: Article

References (20)

1. Kupiec-Weglinski JW, Diamantstein T, Tilney NL. Interleukin 2 receptor-targeted therapy: rationale and applications in organ transplantation. Transplantation 1988; 46: 785.
2. Soulillou JP, Cantarovich D, Le Mauff B, et al. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antilymphocyte globulin for prophylaxis against rejection of renal allografts. N Engl J Med 1990; 332: 1175.
3. Van Gelder T, Zietse R, Mulder AH, et al. A double-blind, placebo-controlled study of monoclonal anti-interleukin-2 receptor antibody (BT563) administration to prevent acute rejection after kidney transplantation. Transplantation 1995; 60: 248.
4. Simpson MA, Madras PN, Cornaby AJ, et al. Sequential determinations of urinary cytology and plasma and urinary lymphokines in the management of renal allograft recipients. Transplantation 1989; 47: 218.
5. Forsythe JLR, Shenton BK, Parrott NR, et al. Plasma interleukin 2 receptor levels in renal allograft dysfunction. Transplantation 1989; 48: 155.
6. Colvin RB, Preffer FI, Fuller TC, et al. A critical analysis of serum and urine interleukin 2 receptor assays in renal allograft recipients. Transplantation 1989; 48: 800.
7. Noronha IL, Daniel V, Mohring K, Opelz G. Analysis of plasma interleukin-2 receptor (sIL-2R) and tumor necrosis factor-alpha (TNF-a) in renal transplant patients. Clin Transplant 1992; 6: 277.
8. Schroeder TJ, Helling T, McKenna RM, et al. A multicenter study to evaluate a novel assay for quantitation of soluble interleukin 2 receptor in renal transplantation recipients. Transplantation 1992; 53: 34.
9. Malcus C, Pouteil-Noble C, Touraine F, et al. Plasma soluble interleukin-2 receptor (IL-2RS) level and activation markers in blood in the follow-up of renal allograft patients. Transplant Proc 1990; 22: 1865.
10. Plaza JJ, Blum G, Ortiz A, et al. Usefulness of serum interleukin 2 receptor levels in renal allograft recipients. Transplant Proc 1992; 24: 63.
11. Manfro RC, Pohanka E, Tomlanovich SJ, et al. Determination of soluble IL-2 receptors in kidney graft recipients: a 6 month follow-up. Transplant Proc 1990; 22: 1861.
12. Di Stefano R, Carmellini M, Zucchelli G, et al. Interleukin-2 receptor levels in end-stage renal disease and transplant patients. Transplant Proc 1990; 22: 1863.
13. Yussim A, Shapira Z, Shohat B, et al. The assay of soluble IL-2 receptor levels in graft microenvironment can be helpful in differential diagnosis of transplant dysfunction. Transplant Proc 1991; 23: 260.
14. Olson P, Manack L, Miller L, et al. Long-term soluble interleukin-2 receptor level of heart transplant recipients. Clin Transplant 1993; 7: 541.
15. Jutte NHPM, Hesse CJ, Balk AHMM, et al. Sequential measurements of soluble interleukin 2 receptor levels in plasma of heart transplant recipients. Transplantation 1990; 50: 328.
16. Bock GH, Neu L, Long C, et al. An assessment of serum and urine soluble interleukin-2 receptor concentrations during renal transplant rejection. Am J Kidney Dis 1994; 23: 241.
17. Pollak R, Fabrega AJ, Vasquez E, et al. Measurement of serum-soluble interleukin 2 receptor levels following renal transplantation. Transplantation 1995; 59: 926.
18. Kutukculer N, Clark K, Rigg KM, et al. The value of posttransplant monitoring of interleukin (IL)-2, IL-3, IL-4, IL-6, IL-8, and soluble CD23 in the plasma of renal allograft recipients. Transplantation 1995; 59: 333.
19. + human T cells. Transplantation 1996; 62: 1095.
20. Theze J, Alzari PM, Bertoglio J. Interleukin 2 and its receptors: recent advances and new immunological functions. Immunol Today 1996; 17: 481.